COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 36.57 |
| 52 Week High | 36.96 |
| 52 Week Low | 20.05 |
| Avg. Daily Vol. (Mil) | 19.98 |
| Beta (3 year) | 0.82 |
| Share Related Items | |
| Mkt Cap (Mil) | 77,132.64 |
| Shares Out (Mil) | 2,109.18 |
| Float (Mil) | 2,108.16 |
| Dividend Information | |
| Yield % | 4.20 |
| Annual Dividend | 1.52 |
| Payout Ratio | 40.00 |
| Financial Strength | |
| Quick Ratio | 3.20 |
| Current Ratio | 3.70 |
| LT Debt/ Equity | 0.36 |
| Total Debt / Equity | 0.40 |
| Valuation Ratios | |
| Price Earnings | 9.60 |
| Price/Sales | 3.30 |
| Price/Book | 3.37 |
| Price/Cash Flow | 7.80 |
| Per Share Data | |
| Earnings | 3.80 |
| Sales | 11.08 |
| Book Value | 10.86 |
| Cash Flow | 4.70 |
| Business Summary | |
|---|---|
| Al research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. | |
| General Information | |
| One Merck Drive
P. O. Box 100 Whitehouse Station, NJ 08889-0100 |
|
| www.merck.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 55200 | |
| CEO: Richard T. Clark | |
| Short Interest | |
| Current Month (Mil) | 47.52 |
| Previous Month (Mil) | 206.48 |
| Short Interest Ratio (Days) | 1.90 |
| Management Effectiveness | |
| Return on Equity | 35.40 |
| Return on Assets | 16.60 |
| Return on Investments | 26.10 |
| Profitability | |
| Gross Margin | 83.80 |
| EBIT Margin | 47.50 |
| Profit Margin | 34.70 |